News from surface ophthalmics, inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Mar 31, 2021, 08:38 ET Surface Ophthalmics Announces Preeya K. Gupta, MD as Chief Medical Advisor

PLEASANTON, Calif., March 31, 2021 Surface Ophthalmics, Inc., a pharmaceutical company focused on the development and commercialization of innovative ...

Feb 04, 2021, 08:47 ET Surface Ophthalmics Announces First Patient Dosed in Phase II Trial for SURF-200 for Acute Dry Eye

Surface Ophthalmics, Inc., a pharmaceutical company focused on the development and commercialization of innovative therapeutics for ocular diseases,...

Jan 27, 2021, 08:00 ET Surface Ophthalmics Announces First Patient Dosed in Landmark Head-to-Head Phase II Trial for SURF-100 for Chronic Dry Eye Disease

Surface Ophthalmics, Inc., a pharmaceutical company focused on the development and commercialization of innovative therapeutics for ocular diseases,...

Jan 21, 2021, 09:23 ET Surface Ophthalmics Announces Positive Top-Line Results from Phase II Trial for SURF-201 (Betamethasone 0.2% in Klarity® vehicle) for the Treatment of Post-Cataract Surgery Pain and Inflammation

Surface Ophthalmics, Inc., a pharmaceutical company focused on the development and commercialization of innovative therapeutics for ocular diseases,...

Jan 07, 2021, 12:15 ET Surface Ophthalmics Previews Important Clinical Progress in 2021

Surface Ophthalmics, Inc., a pharmaceutical company focused on development and commercialization of innovative therapeutics for ocular diseases, is...